Omada Health, Inc. (OMDA) 股票分析

公司概述

Omada Health, Inc. operates within the healthcare sector, specifically focusing on the health information services industry, where it delivers virtual care programs across the United States. The company provides a comprehensive suite of digital health solutions, including cardiometabolic programs targeting prediabetes, diabetes, and hypertension, alongside physical therapy initiatives for musculoskeletal conditions. With a market capitalization of $738.34 million and a workforce comprising 916 employees, Omada Health demonstrates a significant operational footprint in the digital therapeutics landscape. The annual revenue of $260.21 million indicates that the company has established substantial commercial traction, positioning it as a notable player capable of scaling its virtual care infrastructure to meet growing demand for accessible health management solutions.

财务健康

Omada Health reported a trailing twelve-month revenue of $260.21 million, yet recorded a net income of -$12,778,000 and an EBITDA of -$6,481,000, revealing a cost structure where operating expenses significantly outpace current profitability. Despite the reported net loss, the company generated positive free cash flow of $15.34 million, which highlights a strong ability to generate liquidity from operations and suggests considerable financial flexibility for strategic investments or debt reduction. The gross margin stands at 65.7%, reflecting efficient production and delivery costs relative to revenue, while the operating margin of 4.3% and profit margin of -4.9% indicate that general and administrative expenses are currently eroding bottom-line profitability. The balance sheet presents a conservative profile with $222.32 million in cash holdings against zero total debt, effectively eliminating interest obligations and financial leverage risks. This robust liquidity position is further supported by a current ratio of 3.60, signaling that the company holds more than three times the liquid assets necessary to cover its short-term liabilities. Furthermore, the return on equity of -8.7% and return on assets of -3.3% reflect that management has not yet achieved positive returns on shareholder capital or total assets, a common characteristic for high-growth firms still navigating the path to sustained profitability.

估值评估

The valuation metrics show a trailing P/E ratio of N/A due to the net loss, while the forward P/E is calculated at 34.94, implying that the market prices the stock based on expected future earnings rather than current performance. The price-to-book ratio of 3.19 suggests that the market values Omada Health at a significant premium over its book value, reflecting expectations of future growth and intangible asset appreciation. Alternative valuation measures such as the price-to-sales ratio of 2.84 and an EV/EBITDA of -79.62 provide additional context, indicating that investors are willing to pay a multiple of nearly three times sales despite current negative cash conversion relative to earnings. In terms of trading range, the stock has fluctuated between a 52-week high of $28.40 and a low of $10.28, with the current trading price sitting at a level that requires calculation relative to this historical band to determine its position within the annual volatility spectrum. Although the beta is listed as N/A, the absence of a specific volatility metric relative to the broader market suggests that the stock's price movements may be driven more by specific industry fundamentals than broad market correlations in this data snapshot.

Growth & Income

Omada Health demonstrated a robust revenue growth of 58.1% year-over-year, whereas earnings growth is listed as N/A due to the company's current net loss status, indicating that top-line expansion is outpacing bottom-line profitability in the current fiscal period. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company currently retains all of its earnings to reinvest into research, development, and market expansion rather than distributing income to shareholders. This strategy aligns with the capital-intensive nature of scaling virtual care programs, where capital deployment is prioritized to drive future revenue streams rather than providing immediate income returns. The overall growth and income profile characterizes Omada Health as a high-potential growth asset that sacrifices current income distribution to fuel rapid market penetration and operational scaling within the competitive health information services industry.